Consultation: NENC Primary Care Management of Insomnia in Adults

Following the September 2026 NENC Clinical Guidelines & Pathways Group we now seek comments from across the NENC ICB on this new draft NENC Guidelines on the Primary Care Management of Insomnia in Adults.  

This guideline has been developed NENC ICB Medicines Optimisation Team with input from GP, Mental Health Trusts and the Paediatric and Adult Sleep Service at Newcastle Hospitals.

As part of this consultation we are also seeking views on changing the formulary status of daridorexant from GREEN+ to a GREEN drug. This is because not all parts of the ICB have a service within their local Trust to which they can refer patients to for primary insomnia

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the Clinical Guidelines & Pathways Group/NTAG, and used to inform the final version that is presented for approval in the NENC.

All comments will be reviewed but please do not expect a personal reply as we do not routinely reply to all comments. It is important to include any relevant evidence to back up any suggestions and please keep comments concise where possible.

All comments received will shared unedited with the authors/working group who are developing the document to support the production of a final draft for approval.

Please note

1. The messages sent from this form are transmitted via our host’s web server. If you have any security concerns about this process you can send your comments/feedback using your own email client to nuth.nyrdtc.rxsupp@nhs.net
2. This consultation will run for four weeks and closes on Friday 14th August at 5pm.

Name *

Email *

Email

Confirm Email

Job title *

Employer *

Locality

Are you responding on behalf of an organisation or as an individual? *

• On behalf of an organisation or organisational leader
• As an individual

Please specify who you are responding for, including job title and organisation as appropriate

Do you / your organisation support the implementation of this guideline

• Yes
• No

What barriers may prevent you / your organisation from implementing the full guidance?

If there are barriers to implementation what would help resolve these?

Do you have any additional comments?

Submit